Issues in interpreting drug discovery data

被引：0

作者：

Stouch, Terry R. ^{[1
]}

机构：

[1] Sci Solut, Dept Res Consulting, Princeton, NJ 08550 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 243卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

541-COMP

引用

页数：1

共 50 条

[1] Target selection issues in drug discovery and development
Sausville, EA
JOURNAL OF CHEMOTHERAPY, 2004, 16 : 16 - 18
[2] Linked Data in Drug Discovery
Dumontier, Michel
Wild, David J.
IEEE INTERNET COMPUTING, 2012, 16 (06) : 68 - 71
[3] Data management for drug discovery
Fox, Sophia
GENETIC ENGINEERING NEWS, 2006, 26 (19): : 40 - 40
[4] Drug Disposition Issues in CKD: Implications for Drug Discovery and Regulatory Approval
Tieu, Alvin
House, Andrew A.
Urquhart, Bradley L.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2016, 23 (02) : 63 - 66
[5] MULTINATIONAL DRUG COMPANIES - ISSUES IN DRUG DISCOVERY AND DEVELOPMENT - SPILKER,B
BOVET, D
HISTORY AND PHILOSOPHY OF THE LIFE SCIENCES, 1990, 12 (02): : 302 - 303
[6] Digitizing chemical discovery with a Bayesian explorer for interpreting reactivity data
Mehr, S. Hessam M.
Caramelli, Dario
Cronin, Leroy
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (17)
[7] Issues in interpreting and estimating the excess risk in case of count data
Tedeschi, Federico
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2019, 107 : 126 - 127
[8] Issues in interpreting and using genome-wide sequence data
Durbin, Richard
JOURNAL OF MEDICAL GENETICS, 2010, 47 : S18 - S18
[9] TB drug discovery: addressing issues of persistence and resistance
Smith, CV
Sharma, V
Sacchettini, JC
TUBERCULOSIS, 2004, 84 (1-2) : 45 - 55
[10] BIOTECHNOLOGY IN THE DRUG DISCOVERY PROCESS - STRATEGIC AND MANAGEMENT ISSUES
WILLIAMS, M
GIORDANO, T
ELDER, RA
REISER, HJ
NEIL, GL
MEDICINAL RESEARCH REVIEWS, 1993, 13 (04) : 399 - 448

← 1 2 3 4 5 →